Nebivolol: Endothelium‐Mediated Vasodilating Effect

@article{Ritter2001NebivololEV,
  title={Nebivolol: Endothelium‐Mediated Vasodilating Effect},
  author={J. Ritter},
  journal={Journal of Cardiovascular Pharmacology},
  year={2001},
  volume={38},
  pages={S13–S16}
}
  • J. Ritter
  • Published 2001
  • Medicine
  • Journal of Cardiovascular Pharmacology
    • Summary: Nebivolol, a racemic mixture of (S,R,R,R) and (R,S,S,S) enantiomers, is the most &bgr;1‐selective adrenoceptor antagonist currently available for clinical use. However, its haemodynamic effects differ from those of classical &bgr;‐adrenoceptor antagonists as a result of a vasodilating action. Nebivolol is devoid of &agr;‐adrenergic antagonist actions, and the detailed mechanism of its vasodilator action is unknown. Nebivolol relaxes precontracted strips of canine coronary and carotid… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    86 Citations
    Highly Influential Citations
    2
    Background Citations
    18
    Results Citations
    4
    86 Citations
    Citation Type

    Citation Type

    Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
    • R. Weiss
    • Medicine
    • Vascular health and risk management
    • 2006
    • 58
    • PDF
    Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
    • 36
    • PDF
    Estrogen Receptor-Mediated Vascular Responsiveness to Nebivolol: A Novel Endothelium-Related Mechanism of Therapeutic Vasorelaxation
    • 43
    The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.
    • 60
    Nebivolol: a review
    • 29
    RESEARCH PAPER Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta
    • 11
    Involvement of the &bgr;3 Adrenoceptor in Nebivolol-Induced Vasorelaxation in the Rat Aorta
    • 79
    MECHANISMS UNDERLYING NEBIVOLOL‐INDUCED ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVATION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS
    • 49
    Mixed β3‐adrenoceptor agonist and α1‐adrenoceptor antagonist properties of nebivolol in rat thoracic aorta
    • 54
    • Highly Influenced
    Nebivolol and carvedilol induce NO-dependent coronary vasodilatation that is unlikely to be mediated by extracellular ATP in the isolated guinea pig heart
    • 5
    • PDF

    References

    SHOWING 1-10 OF 33 REFERENCES
    Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    • 342
    Nitric oxide mediated venodilator effects of nebivolol.
    • 162
    • PDF
    Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries
    • 162
    Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.
    • 220
    • PDF
    Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
    • 87
    Contribution of nitric oxide to beta2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature.
    • 33
    Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitro
    • 165
    Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm.
    • 223
    The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
    • 131
    Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
    • 106
    • PDF